ArticleNAR molecular medicine2025

Targeted deletions in human mitochondrial DNA engineered by Type V CRISPR-Cas12a system.

Natalia Nikitchina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.